Literature DB >> 10131634

Cholesterol screening and cholesterol lowering treatment.

T A Sheldon1, F Song, G D Smith, N Freemantle, J Mason, A Long.   

Abstract

Entities:  

Mesh:

Year:  1993        PMID: 10131634      PMCID: PMC1055099          DOI: 10.1136/qshc.2.2.134

Source DB:  PubMed          Journal:  Qual Health Care        ISSN: 0963-8172


× No keyword cloud information.
  17 in total

1.  Blood cholesterol: is population screening warranted in the UK?

Authors:  W C Smith; M B Kenicer; A M Davis; A E Evans; J Yarnell
Journal:  Lancet       Date:  1989-02-18       Impact factor: 79.321

Review 2.  Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study.

Authors:  W B Kannel; W P Castelli; T Gordon
Journal:  Ann Intern Med       Date:  1979-01       Impact factor: 25.391

3.  Quality of plasma cholesterol measurements in primary care.

Authors:  P M Broughton; D G Bullock; R Cramb
Journal:  BMJ       Date:  1989-02-04

4.  Identification and treatment of risk factors for coronary heart disease in general practice: a possible screening model.

Authors:  A Jones; D H Davies; J R Dove; M A Collinson; P M Brown
Journal:  Br Med J (Clin Res Ed)       Date:  1988-06-18

5.  Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361,662 men.

Authors:  M J Martin; S B Hulley; W S Browner; L H Kuller; D Wentworth
Journal:  Lancet       Date:  1986-10-25       Impact factor: 79.321

Review 6.  Labeling of participants in high blood pressure screening programs. Implications for blood cholesterol screenings.

Authors:  R C Lefebvre; K G Hursey; R A Carleton
Journal:  Arch Intern Med       Date:  1988-09

7.  The variability of serum cholesterol measurements: implications for screening and monitoring.

Authors:  S G Thompson; S J Pocock
Journal:  J Clin Epidemiol       Date:  1990       Impact factor: 6.437

8.  Can health screening damage your health?

Authors:  H G Stoate
Journal:  J R Coll Gen Pract       Date:  1989-05

9.  Does cholesterol screening result in negative labeling effects? Results of the Massachusetts Model Systems for Blood Cholesterol Screening Project.

Authors:  S Havas; J Reisman; L Hsu; L Koumjian
Journal:  Arch Intern Med       Date:  1991-01

10.  Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT).

Authors:  J Stamler; D Wentworth; J D Neaton
Journal:  JAMA       Date:  1986-11-28       Impact factor: 56.272

View more
  1 in total

1.  Cholesterol and coronary heart disease: screening and treatment.

Authors:  S Ebrahim; G D Smith; C McCabe; N Payne; M Pickin; T A Sheldon; F Lampe; F Sampson; S Ward; G Wannamthee
Journal:  Qual Health Care       Date:  1998-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.